Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.
dc.contributor.author | Yalcin, Suayib | |
dc.contributor.author | Dane, Faysal | |
dc.contributor.author | Oksuzoglu, Berna | |
dc.contributor.author | Yildirim, Nuriye | |
dc.contributor.author | Isikdogan, Abdurrahman | |
dc.contributor.author | Ozkan, Metin | |
dc.contributor.author | Demirag, Guzin | |
dc.contributor.author | Coskun, Hasan Senol | |
dc.contributor.author | Karabulut, Bulent | |
dc.contributor.author | Evrensel, Turkkan | |
dc.contributor.author | Ustaoglu, Mehmet Ali | |
dc.contributor.author | Ozdemir, Feyyaz | |
dc.contributor.author | Turna, Hande | |
dc.contributor.author | Yavuzsen, Tugba | |
dc.contributor.author | Aykan, Faruk | |
dc.contributor.author | Sevinc, Alper | |
dc.contributor.author | Akbulut, Hakan | |
dc.contributor.author | Yuce, Deniz | |
dc.contributor.author | Hayran, Mutlu | |
dc.contributor.author | Kilickap, Saadettin | |
dc.date.accessioned | 2019-10-27T10:42:20Z | |
dc.date.available | 2019-10-27T10:42:20Z | |
dc.date.issued | 2018 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | Gastrointestinal Cancers Symposium -- JAN 18-20, 2018 -- San Francisco, CA | en_US |
dc.identifier.doi | 10.1200/JCO.2018.36.4_suppl.346 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.uri | https://doi.org/10.1200/JCO.2018.36.4_suppl.346 | |
dc.identifier.uri | https://hdl.handle.net/11454/30692 | |
dc.identifier.volume | 36 | en_US |
dc.identifier.wos | WOS:000436174100331 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Soc Clinical Oncology | en_US |
dc.relation.ispartof | Journal of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study. | en_US |
dc.type | Conference Object | en_US |